AVTR:NYE-Avantor Inc (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 15.22

Change

0.00 (0.00)%

Market Cap

USD 11.92B

Volume

0.02B

Analyst Target

USD 23.81
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-12 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

N/A

USD 57.94B
ALC Alcon AG

N/A

USD 44.32B
RMD ResMed Inc

N/A

USD 31.43B
BAX Baxter International Inc

N/A

USD 14.28B
SOLV Solventum Corp.

N/A

USD 11.45B
ATR AptarGroup Inc

N/A

USD 9.51B
TFX Teleflex Incorporated

N/A

USD 6.39B
STVN Stevanato Group SpA

N/A

USD 5.98B
BLCO Bausch + Lomb Corp

N/A

USD 4.29B
WRBY Warby Parker Inc

N/A

USD 1.79B

ETFs Containing AVTR

COPP Sprott Copper Miners ETF 10.10 % 0.00 %

N/A

N/A
CEBS:XETRA iShares Copper Miners UCI.. 5.64 % 0.00 %

N/A

USD 0.06B
WIRE:AU Global X Copper Miners ET.. 5.25 % 0.00 %

N/A

N/A
4COP:XETRA Global X Copper Miners UC.. 5.24 % 0.00 %

N/A

USD 0.09B
COPG:LSE Global X Copper Miners UC.. 5.14 % 0.00 %

N/A

USD 0.15B
COPX Global X Copper Miners ET.. 4.88 % 0.65 %

N/A

USD 2.23B
XMET:AU BetaShares Energy Transit.. 4.85 % 0.00 %

N/A

N/A
COPA Themes Copper Miners ETF 4.57 % 0.00 %

N/A

USD 0.50M
COPX:SW Global X Copper Miners UC.. 4.56 % 0.00 %

N/A

N/A
D6AT:XETRA Global X Disruptive Mater.. 4.46 % 0.00 %

N/A

N/A
GMTL:AU Global X Green Metal Mine.. 4.40 % 0.00 %

N/A

N/A
COPX:LSE Global X Copper Miners UC.. 4.31 % 0.00 %

N/A

N/A
DMAT Global X Disruptive Mater.. 3.67 % 0.00 %

N/A

USD 4.90M
SETM:LSE 3.14 % 0.00 %

N/A

N/A
IJJ iShares S&P Mid-Cap 400 V.. 0.81 % 0.25 %

N/A

USD 6.97B
BSJO 0.00 % 0.42 %

N/A

N/A
IVOV Vanguard S&P Mid-Cap 400 .. 0.00 % 0.20 %

N/A

USD 0.87B
HYDW Xtrackers Low Beta High Y.. 0.00 % 0.25 %

N/A

USD 0.19B
PQIN 0.00 % 0.00 %

N/A

N/A
IESZ:LSE 0.00 % 0.00 %

N/A

N/A
EXV6:F 0.00 % 0.00 %

N/A

N/A
EXV6:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

USD 0.37B
CRIT Optica Rare Earths & Crit.. 0.00 % 0.00 %

N/A

USD 3.25M
BRHY BlackRock High Yield ETF 0.00 % 0.00 %

N/A

USD 0.10B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -27.76% 26% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -27.76% 26% F 10% F
Trailing 12 Months  
Capital Gain -39.02% 16% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -39.02% 11% F 8% B-
Trailing 5 Years  
Capital Gain 9.58% 67% D+ 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.58% 67% D+ 26% F
Average Annual (5 Year Horizon)  
Capital Gain 6.19% 72% C 59% D-
Dividend Return 6.19% 72% C 52% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 41.46% 44% F 21% F
Risk Adjusted Return 14.93% 61% D- 33% F
Market Capitalization 11.92B 73% C 88% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector